Age, Homocysteine, and Oxidative Stress: Relation to Hypertension and Type 2 Diabetes MellitusFootnote

There is no conflict of interest.

REFERENCES

• WelchGNLoscalzoJ: Homocysteine and atherothrombosis. N Engl J Med 338: 1042– 1050, 1998.
   PubMed Web of Science ®Google Scholar
• WaldDSLawMMorrisJK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. B Med J 325: 1202– 1206, 2002.
   PubMed Web of Science ®Google Scholar
• Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288: 2015– 2022, 2002.
   PubMed Web of Science ®Google Scholar
• RidkerPMBrownNJVaughanDEHarrisonDGMehtaJL: Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109: IV6– 19, 2004.
   PubMed Web of Science ®Google Scholar
• AmesBNShigenagaMKHagenTM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90: 7915– 7922, 1993.
   PubMed Web of Science ®Google Scholar
• TouyzRM: Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248– 252, 2004.
   PubMed Web of Science ®Google Scholar
• BrownleeM: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615– 1625, 2005.
   PubMed Web of Science ®Google Scholar
• SelhubJJacquesPFWilsonPWRushDRosenbergIH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270: 2693– 2698, 1993.
   PubMed Web of Science ®Google Scholar
• LippiGArosioEPriorMGuidiG: Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens. Angiology 52: 681– 687, 2001.
   PubMedGoogle Scholar
• HarmanD: Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298– 300, 1956.
   PubMedGoogle Scholar
• ChobanianAVBakrisGLBlackHRCushmanWCGreenLAIzzoJLJonesDWMatersonBJOparilSWrightJTRoccellaEJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560– 2572, 2003.
   PubMed Web of Science ®Google Scholar
• LewingtonSClarkeRQizilbashNPetoRCollinsR: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903– 1913, 2002.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association: Clinical practice recommendations 2005. Diabetes Care 28 (suppl 1): S1– S79, 2005.
   Google Scholar
• FriedewaldWTLevyRIFredricksonDS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499– 502, 1972.
   PubMed Web of Science ®Google Scholar
• TooleJFMalinowMRChamblessLESpenceJDPettigrewLCHowardVJSidesEGWangCHStampferM: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291: 565– 575, 2004.
   PubMed Web of Science ®Google Scholar
• BonaaKHNjolstadIUelandPMSchirmerHTverdalASteigenTWangHNordrehaugJEArnesenERasmussenK: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354: 1578– 1588, 2006.
   PubMed Web of Science ®Google Scholar
• LonnEYusufSArnoldMJSheridanPPogueJMicksMMcQueenMJProbstfieldJFodorGHeldCGenestJ: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354: 1567– 1577, 2006.
   PubMed Web of Science ®Google Scholar
• EbbingMBleieØUelandPMNordrehaugJENilsenDWVollsetSERefsumHPedersonEKRNygardO: Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography. JAMA 300: 795– 804, 2008.
   PubMed Web of Science ®Google Scholar
• AlbertCMCookNRGazianoJMZaharrisEMacFaydenJDanielsonEBuringJEMansonJE: Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. JAMA 299: 2027– 2036, 2008.
   PubMed Web of Science ®Google Scholar
• Kris-EthertonPMLichtensteinAHHowardBVSteinbergDWitztumJL: Antioxidant vitamin supplements and cardiovascular disease. Circulation 110: 637– 641, 2004.
   PubMed Web of Science ®Google Scholar
• LakattaEG: Central arterial aging and the epidemic of systolic hypertension and atherosclerosis. J Am Soc Hypertens 1: 302– 340, 2007.
   Google Scholar
• McCullyKS: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111– 128, 1969.
   PubMed Web of Science ®Google Scholar
• MangoniAAJacksonSH: Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 112: 556– 565, 2002.
   PubMed Web of Science ®Google Scholar
• GoriAMCorsiAMFediSGazziniASofiFBartaliBBandinelliSGensiniGFAbbateRFerrucciL: A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr 82: 335– 341, 2005.
   PubMed Web of Science ®Google Scholar
• LimUCassanoPA: Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol 156: 1105– 1113, 2002.
   PubMed Web of Science ®Google Scholar
• SignorelloMGVivianiGLArmaniUCeroneRMinnitiGPianaALeonciniG: Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 120: 607– 613, 2006.
   Google Scholar
• van GuldenerCStehouwerCD: Diabetes mellitus and hyperhomocysteinemia. Semin Vasc Med 2: 87– 95, 2002.
   Google Scholar
• VangelderEDelecourtFCardozoMBDhondtJLForzyG: Hyperhomocysteinaemia and type 2 diabetes. Ann Biol Clin 64: 485– 489, 2006.
   Google Scholar
• SigurdardottirVFagerbergBHultheJ: Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 252: 440– 447, 2002.
   PubMed Web of Science ®Google Scholar
• FurukawaSFujitaTShimabukuroMIwakiMYamadaYNakajimaYNakayamaOMakishimaMMatsudaMShimomuraI: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752– 1761, 2004.
   PubMed Web of Science ®Google Scholar
• TribbleDL: AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasison vitamin C, vitamin E, and beta-carotene: a statement for healthcare professionals from the American Heart Association. Circulation 99: 591– 595, 1999.
   PubMed Web of Science ®Google Scholar
• SternMP: Diabetes and cardiovascular disease. The “common soil” hypothesis. Diabetes 44: 369– 374, 1995.
   PubMed Web of Science ®Google Scholar